1. Home
  2. ABVX vs CAL Comparison

ABVX vs CAL Comparison

Compare ABVX & CAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABVX
  • CAL
  • Stock Information
  • Founded
  • ABVX 2013
  • CAL 1878
  • Country
  • ABVX France
  • CAL United States
  • Employees
  • ABVX N/A
  • CAL N/A
  • Industry
  • ABVX
  • CAL Shoe Manufacturing
  • Sector
  • ABVX
  • CAL Consumer Discretionary
  • Exchange
  • ABVX Nasdaq
  • CAL Nasdaq
  • Market Cap
  • ABVX 451.5M
  • CAL 520.3M
  • IPO Year
  • ABVX N/A
  • CAL N/A
  • Fundamental
  • Price
  • ABVX $6.02
  • CAL $13.46
  • Analyst Decision
  • ABVX Buy
  • CAL Hold
  • Analyst Count
  • ABVX 4
  • CAL 1
  • Target Price
  • ABVX $31.50
  • CAL $14.00
  • AVG Volume (30 Days)
  • ABVX 193.4K
  • CAL 1.2M
  • Earning Date
  • ABVX 03-24-2025
  • CAL 05-29-2025
  • Dividend Yield
  • ABVX N/A
  • CAL 2.08%
  • EPS Growth
  • ABVX N/A
  • CAL N/A
  • EPS
  • ABVX N/A
  • CAL 2.43
  • Revenue
  • ABVX $11,172,999.00
  • CAL $2,677,706,000.00
  • Revenue This Year
  • ABVX $284.20
  • CAL $0.93
  • Revenue Next Year
  • ABVX N/A
  • CAL $3.13
  • P/E Ratio
  • ABVX N/A
  • CAL $5.54
  • Revenue Growth
  • ABVX 135.94
  • CAL N/A
  • 52 Week Low
  • ABVX $4.77
  • CAL $13.14
  • 52 Week High
  • ABVX $14.71
  • CAL $44.51
  • Technical
  • Relative Strength Index (RSI)
  • ABVX 46.21
  • CAL 35.14
  • Support Level
  • ABVX $5.59
  • CAL $15.68
  • Resistance Level
  • ABVX $6.09
  • CAL $16.86
  • Average True Range (ATR)
  • ABVX 0.33
  • CAL 0.82
  • MACD
  • ABVX -0.02
  • CAL -0.35
  • Stochastic Oscillator
  • ABVX 41.15
  • CAL 6.24

About ABVX Abivax SA American

Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD.

About CAL Caleres Inc.

Caleres Inc is a footwear company that operates retail shoe stores and e-commerce websites, and designs, develops, sources, manufactures, and distributes footwear for people of all ages. The Company's business operations are organized into two reportable segments - famous Footwear and Brand Portfolio. The famous Footwear segment is comprised of its famous Footwear retail stores, famousfootwear.com, and famousfootwear.ca. The famous Footwear segment operated around 846 stores at the end of 2024. The Brand Portfolio segment offers retailers and consumers a cultivated portfolio of known brands. Geographically, the company generates the majority of its revenue from Domestic operations.

Share on Social Networks: